Financial Statements

Arena Pharmaceuticals, Inc. (ARNA)

$99.99

0.00 (0.00%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) -1,508-1,103-1,501-1,490-
Net Income -616-405398-29-91
Stock Dividends ---19-1,399
Dividend Paid -----
Retained Earnings -2,124-1,508-1,103-1,501-1,490

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 22252330-
Annual Depreciation 68-27-630
Capital Expenditure -71-1-5-1-0
Net PPE 1922252330

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -----
New Purchases -113-365-1,469-1,034-612
Intangible and Goodwill -----

Arena Pharmaceuticals, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Arena Pharmaceuticals, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.